James Patrick Tursi

This profile gathers the share dealings of James Patrick Tursi in Aralez Pharmaceuticals Inc. In total, 13 filings cover trades dated from 6 February 2016 to 14 May 2018.

Both buying and selling appear: 2 purchases worth €37k, against 5 sales worth €26k. On balance, insiders were net buyers of €11k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 option exercises. Since January 2018: no purchases and 4 sales on the market.

Most recently, on 16 May 2018, the filings show an option exercise worth €9,157 in Aralez Pharmaceuticals Inc. The latest purchase dates back some time: it was published 3,821 days ago, on 23 May 2016. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.